K850174 is an FDA 510(k) clearance for the TDX ETHOSUXIMIDE. This device is classified as a Enzyme Immunoassay, Ethosuximide (Class II - Special Controls, product code DLF).
Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on February 6, 1985, 20 days after receiving the submission on January 17, 1985.
This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3380.
| 510(k) Number | K850174 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | January 17, 1985 |
| Decision Date | February 06, 1985 |
| Days to Decision | 20 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | DLF — Enzyme Immunoassay, Ethosuximide |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.3380 |